Yang et al. screened a murine monoclonal antibody, mAbE12, which interferes with the interaction between bFGF and FGFR1, demonstrating the ability to inhibit the proliferation and tumor growth of lung adenocarcinoma (LLC) cells in both in vitro and in vivo experiments [79]. The gene discussed is FGFR1; the disease is neoplasm.